Iruma, Japan

Keiji Yamagami


Average Co-Inventor Count = 5.0

ph-index = 6

Forward Citations = 145(Granted Patents)


Location History:

  • Baltimore, MD (US) (1991)
  • Saitama, JP (1999)
  • Iruma, JP (1991 - 2005)

Company Filing History:


Years Active: 1991-2005

Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Journey of Keiji Yamagami

Introduction

Keiji Yamagami, an accomplished inventor based in Iruma, Japan, has made significant contributions in the field of pharmaceuticals through his innovative work. With a total of nine patents to his name, Yamagami has focused on developing novel therapeutic agents that address various health conditions. His work exemplifies the intersection of science and innovation, driven by a commitment to improve patient outcomes.

Latest Patents

Among Yamagami's most notable inventions is a pharmaceutical agent containing a Rho kinase inhibitor. This novel compound serves multiple therapeutic purposes, including treatment for hypertension, angina pectoris, asthma, and peripheral circulation disorders. Furthermore, it functions as a prophylactic agent for immature birth and digestive tract infections, anti-cancer drug, anti-inflammatory agent, immunosuppressant, and a contraceptive. Additionally, it has applications in osteoporosis, retinopathy treatment, brain function enhancement, and even in diagnostic and reagent capacities. Yamagami's latest patent holds promise for revolutionizing the treatment landscape for numerous diseases, highlighting the versatility and importance of Rho kinase inhibitors.

Career Highlights

Throughout his career, Keiji Yamagami has worked with esteemed organizations such as Yoshitomi Pharmaceutical Industries, Ltd. and Yamasa Shoyu Co., Ltd. His experiences at these companies have undoubtedly shaped his innovative approach to drug development, allowing him to explore new avenues for improving healthcare solutions. Yamagami's dedication to research and development reflects his passion for contributing to the medical field.

Collaborations

In his pursuit of groundbreaking innovations, Yamagami has collaborated with notable coworkers, including Hiroyuki Satoh and Masayoshi Uehata. These partnerships have enriched his work, fostering an environment of shared knowledge and expertise that enhances the potential for impactful inventions.

Conclusion

Keiji Yamagami's journey as an inventor is marked by his commitment to addressing significant health challenges with innovative solutions. His contributions, particularly in the development of Rho kinase inhibitors, illustrate the profound impact that dedicated inventors can have on improving healthcare outcomes. As he continues to explore new horizons, Yamagami exemplifies the essence of innovation and the spirit of advancement in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…